TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 88 filers reported holding TANGO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,576,098 | +239.2% | 495,213 | 0.0% | 0.01% | +300.0% |
| Q2 2023 | $1,644,107 | -15.9% | 495,213 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $1,956,091 | -45.5% | 495,213 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $3,590,294 | +155.7% | 495,213 | +27.6% | 0.01% | +166.7% |
| Q3 2022 | $1,404,000 | +3.5% | 387,953 | +29.6% | 0.00% | 0.0% |
| Q2 2022 | $1,356,000 | +69.3% | 299,391 | +183.4% | 0.00% | +50.0% |
| Q1 2022 | $801,000 | -30.7% | 105,656 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,156,000 | +67.1% | 105,656 | +97.5% | 0.00% | +100.0% |
| Q3 2021 | $692,000 | – | 53,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
| Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
| TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
| Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
| Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
| EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
| Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
| HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
| Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |